Computational drug discovery could open new doors
New AI approaches to drug development could lower treatment costs and make new discoveries possible.
New AI approaches to drug development could lower treatment costs and make new discoveries possible.
A team led by a University of Arizona College of Medicine – Tucson scientist harnesses AI to trace the path from a healthy brain cell to one afflicted by Alzheimer’s disease.
The Arizona Simulation Technology and Education Center developed an artificial intelligence tool to train students to communicate with patients effectively and compassionately.
The new program will allow graduating physicians from the U of A colleges of medicine to enter the workforce one year earlier than those who pursue the traditional four-year degree.